MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Lipoproteins and Cardiovascular Health
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,195 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,195 works in the cohort · of 4,299,418page 13 of 64

Labels cover 13 of 3,195 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,195 of 3,195 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Exome Sequencing in Suspected Monogenic Dyslipidemias
Nathan O. Stitziel, Gina M. Peloso, Marianne Abifadel, Angelo B. Cefalù, Sigrid W. Fouchier, Mohammad Mahdi Motazacker +34 more
2015· article· en· Circulation Cardiovascular Genetics· Medicine
machine prediction:candidate · noneconsensus · none
54
citations
affno abstractunlabeled
Lipid lowering for primary prevention
Salim Yusuf, Eva Lonn, Jackie Bosch
2009· review· en· The Lancet· Medicine
machine prediction:candidate · noneconsensus · none
52
citations
afffundno abstractunlabeled
New Frontiers in Lp(a)-Targeted Therapies
Matthew J. Borrelli, Amer Youssef, Michael B. Boffa, Marlys L. Koschinsky
2019· review· en· Trends in Pharmacological Sciences· Medicine
machine prediction:candidate · noneconsensus · none
52
citations
fundno affunlabeled
Cholesterol-Lowering Agents
Savvas Hadjiphilippou, Kausik K. Ray
2019· review· en· Circulation Research· Medicine
machine prediction:candidate · noneconsensus · none
51
citations
affunlabeled
Update on apolipoprotein B
2021· article· en· Current Opinion in Lipidology· Medicine
machine prediction:candidate · noneconsensus · none
51
citations
affno abstractunlabeled
Next Steps in Primary Prevention of Coronary Heart Disease
Michaël Domanski, Valentı́n Fuster, Francisco Díaz‐Mitoma, Scott M. Grundy, Donald M. Lloyd‐Jones, Muhammad Mamdani +5 more
2015· review· en· Journal of the American College of Cardiology· Medicine
machine prediction:candidate · noneconsensus · none
50
citations
affno abstractunlabeled
Apolipoprotein A1 and B
Allan D. Sniderman, Santica M. Marcovina
2006· review· en· Clinics in Laboratory Medicine· Medicine
machine prediction:candidate · noneconsensus · none
49
citations

How this was built: Screen · Findings · About